FDA says heartburn meds may lead to fracture risk

Posted by PKSD Law Firm on May 27, 2010 in Dangerous Drugs

The Food and Drug Administration warned yesterday that some heartburn medications could increase the risk of hip, wrist and spine fractures in high doses or with long-term use.

The FDA’s decision came after it’s review of several studies that reported an increased risk of hip, wrist and spine fractures after using proton pump inhibitors in high dosages or with long-term use. Proton pump inhibitors are used to treat gastroesophageal reflux disease, stomach and small intestine ulcers and inflammation of the esophagus, along with frequent heartburn.

The medications include:

  • Esomeprazole – sold as Nexium
  • Dexlansoprazole – sold as Dexilant
  • Lansoprazole – sold as Prevacid
  • Omeprazole – sold as Prilosec or Zegerid
  • Pantoprazole – sold as Protonix
  • Rabeprazole – sold as Aciphex

Over the counter medications include:

  • Omeprazole – sold as Prilosec OTC and Zegerid OTC
  • Lansoprazole – sold as Prevacid 24 Hour

The FDA says that the product labeling will be altered, alerting consumers of the possible increased risk.

PKSD is a Wisconsin personal injury law firm handlingdangerous drug cases through out the state.Our personal injury lawyers have successfully represented injured people in almost every county.We know Wisconsin.

Back to top